Gibson Christopher 4
4 · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Filed Apr 10, 2026
Research Summary
AI-generated summary of this filing
Pacific Biosciences (PACB) Director Christopher Gibson Receives Award
What Happened Christopher Gibson, a director of Pacific Biosciences of California, Inc. (PACB), was granted two awards on April 8, 2026: 57,473 restricted stock units (RSUs) and 77,842 derivative awards (totaling 135,315 units). Both grants were reported as acquisition code "A" at $0.00 per share (no cash paid at grant). These are compensatory awards tied to his board service rather than open-market purchases or sales.
Key Details
- Transaction date: 2026-04-08; Filing date: 2026-04-10 (filed timely).
- Grant amounts and price: 57,473 RSUs @ $0.00 and 77,842 derivative awards @ $0.00 (total 135,315 units).
- Shares owned after transaction: Not stated in the filing.
- Footnotes / vesting:
- F1 (RSUs): The 57,473 RSUs vest in equal annual installments on March 3 of 2027, 2028 and 2029, subject to continued service.
- F2 (derivative award/option-like): One-third of the 77,842 shares vest on March 3, 2027, then the remainder vests in equal monthly installments over the following 24 months, subject to continued service.
- No indication of a 10b5-1 plan, tax-withholding sale, or immediate sale of shares in this filing.
Context These grants follow Mr. Gibson’s election to the board on March 3, 2026, and represent typical director compensation rather than a market buy or sell. Awards at $0.00 reflect issuance terms, not market value; actual economic value depends on PACB’s share price as the awards vest. For retail investors, such grants signal alignment of the director’s interests with shareholders but do not by themselves indicate a personal market view.
Insider Transaction Report
- Award
Common Stock
[F1]2026-04-08+57,473→ 111,386 total - Award
Stock Option (right to buy)
[F2]2026-04-08+77,842→ 77,842 totalExercise: $1.52From: 2027-03-03Exp: 2036-04-08→ Common Stock (77,842 underlying)
Footnotes (2)
- [F1]Mr. Gibson was elected to the Board of Directors on March 3, 2026. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 3rd of each of 2027, 2028, and 2029, provided such Reporting Person continues to serve as a director through the applicable vesting dates.
- [F2]One-third of the shares subject to the option will vest on March 3, 2027, which is the one year anniversary of Mr. Gibson joining the Board, and the remainder will vest in equal monthly installments thereafter for 24 months on the same date of the month as his initial start date, provided he continues to serve as a director through each vesting date.